Please complete the required fields and click Save. You will not be able to navigate this site until you complete the form.

CARE: Lupus
This 30 question module includes complications and disparities in Lupus.
About the Activity

Assess your rheumatology medical knowledge and enhance your patient care! With CARE Lupus you receive:
  • 30 case-based, multiple-choice questions with in-depth answer rationales
  • Images and educational links
  • 10 ABIM MOC points and/or up to 10 AMA PRA Category 1 Credits™ with a passing score of 70% or higher
NOTE: It was recently discovered that the correct answer for question #6 is designated incorrectly in this activity. The correct answer for question #6 is answer option C; however, the system is recognizing answer option A as the correct answer. Please submit answer option A as the answer for this question. We apologize for this error.


  • Members and Nonmembers: $50  
  • FITs and Program Director Members*: $25

* FIT members and Program Directors please email to receive a discount code for purchasing at the $25 rate. Please note that discounts/refunds will not be applied if purchased at full price.

CME and MOC Information

Accreditation Statement

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this enduring material for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities. 

Learning Objectives
Upon completion of this activity, learners should be able to:
  • Recognize the varied clinical manifestations and systemic symptoms in patients with lupus
  • Weigh treatment considerations in patients with lupus, including lupus in pregnancy and lupus nephritis
  • Evaluate indications and adverse effects of medications used to treat lupus
  • Appreciate health disparities that contribute to outcomes in lupus
  • Recognize the immunology and pathophysiology that drives the clinical manifestations seen in lupus
  • Address health maintenance considerations specific to patients with lupus

Maximum ABIM MOC Points: 10

Maximum AMA PRA Category 1 Credits™: 10

Release Date: August 24, 2015

Expiration Date:
August 24, 2018*
* You can claim MOC points and CME credits until the module retires.


Use of Professional Judgment
The CARE Program, including all educational links is intended to be used as a tool to assess the rheumatology base medical knowledge of the learner. The information presented relates to basic principles of diagnosis and therapy, and is meant in no way to substitute for an individual patient assessment based upon the healthcare provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient.

Drugs and Doses

When prescribing medications, the health professional is advised to check the prescribing information accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. The CARE: Lupus Program has been independently planned by the Self-Assessment Program Development Group under the Continuous Professional Development Committee, and the ACR Committee on Education.

CARE Lupus Development Faculty Disclosures
View ACR’s ACCME disclosure practices here

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau
  9. Other

The faculty reported the following disclosures:

Name of Individual

Name of Commercial Interest

Sarah Chisolm, MD, MPH


Megan Clowse, MD, MPH

UCB5, Pfizer2, Janssen2

Jason Cobb, MD

Abbvie2, MedImmune2, American Society of Nephrology2

Mary Anne Dooley, MD, MPH

GSK5,8, Lupus Foundation of America6, Aurinia5, Biogenidek5, UCB5, EMD Serono5, Medimmune5, Lily5, Genentec5, Lupus Clinical Trials Consortium6, BMS9

Candace Feldman, MD, MPH


Joanne Michelle Kahlenberg, MD, PhD


Karen Law, MD


S. Sam Lim, MD, MPH


Amanda Sammut, MD


The production of this activity was supported by Grant Number 1 CPIMP141065-01-00 from the U.S. Department of Health and Human Services Office of Minority Health (HHS, OMH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the HHS, OMH. No commercial support was obtained.

System Requirements

View our system requirements here

MOC Medical Knowledge
Claim CME/CE and MOC
Online Courses
Annual Meeting
Credit Information
ACCME > AMA PRA Category 1 Credit
Available: 10 Credits
Earned: 0 Credits
Release Date: 8/24/2015
Expiration Date: 8/24/2018

ACRh > Participation
Available: 10 Hours
Earned: 0 Hours
Release Date: 8/24/2015
Expiration Date: 8/24/2018

Title and navigation
<<<February 2019>>>
February 2019